Jagsonpal Pharmaceuticals Ltd vs Divi's Lab.
Side-by-side stock comparison based on AI earnings call analysis
Which stock has stronger management signals?
Both companies need to be compared on revenue growth quality, margin trajectory and management commentary.
Jagsonpal Pharmaceuticals Ltd and Divi's Lab. show active capex signals based on earnings call analysis.
No strong fundraising signal is currently visible for either company.
| Metric | Jagsonpal Pharmaceuticals Ltd | Divi's Lab. |
|---|---|---|
| Current Price | ₹226 | ₹8,500 |
| Market Cap | ₹1,578.8 Cr. | ₹2.28 L Cr. |
| Industry | Pharmaceuticals & Biotechnology | Pharmaceuticals & Biotechnology |
| P/E Ratio | 33.58 | 76.59 |
| ROE (%) | 17.3 | 16.53 |
| Debt/Equity | 0.03 | — |
| Sales Growth 5Y (%) | 8.85 | 8.67 |
| Profit Growth 5Y (%) | 42.5 | 39.07 |
| Promoter Holding (%) | 69.06 | 51.88 |
| Revenue Rank | Rank 3 | Rank 3 |
| Margin Rank | Rank 1 | Rank 3 |
| Signal | — | — |
| Capex | Yes | Yes |
| Fundraise | No information | No information |